BiotechTube
Home/Unravel Biosciences/Frederic Vigneault, PhD
FV

Frederic Vigneault, PhD

CSO & Co-Founder

Unravel Biosciences

Therapeutic Areas

NeurologyRare DiseasesComplex Disorders

Unravel Biosciences Pipeline

DrugIndicationPhase
RVL-001 (vorinostat)Rett SyndromeClinical Trial Initiated
New Chemical EntityRett Syndrome and other disordersPre-clinical

Leadership Team at Unravel Biosciences

RN
Richard Novak, PhD
CEO & Co-Founder
NM
Neal Muni, MD, MSPH
CMO
View full Unravel Biosciences profile